SLS BIO Co (XKRX:246250) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. SLS BIO Co's Free Cash Flow for the three months ended in Mar. 2024 was ₩0 Mil. SLS BIO Co's Revenue for the three months ended in Mar. 2024 was ₩2,048 Mil. Therefore, SLS BIO Co's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, SLS BIO Co's current FCF Yield % is 3.47%.

The historical rank and industry rank for SLS BIO Co's FCF Margin % or its related term are showing as below:

XKRX:246250' s FCF Margin % Range Over the Past 10 Years
Min: -21.88 Med: 0.42 Max: 30.69
Current: 19.23

During the past 9 years, the highest FCF Margin % of SLS BIO Co was 30.69%. The lowest was -21.88%. And the median was 0.42%.

XKRX:246250's FCF Margin % is ranked better than
89.64% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs XKRX:246250: 19.23

SLS BIO Co FCF Margin % Historical Data

The historical data trend for SLS BIO Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co FCF Margin % Chart

SLS BIO Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

17.89

-4.76

17.85

30.69

22.47

SLS BIO Co Quarterly Data
	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial			34.52	-	41.60	15.91	-

Competitive Comparison of SLS BIO Co's FCF Margin %

For the Diagnostics & Research subindustry, SLS BIO Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SLS BIO Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's FCF Margin % falls into.

SLS BIO Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

SLS BIO Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2027.242	/	9023.399
	=	22.47 %

SLS BIO Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	2048.418
	=	0.00 %

SLS BIO Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229

Website

http://www.slabs.co.kr

SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines